About
Technology
Applications
Partnerships
News
Team
Careers
Contact
About
Technology
Applications
Partnerships
News
Team
Careers
Contact
Combining human and machine intelligence to accelerate the discovery of advanced medicines.
Scroll
Combining human and machine
intelligence to accelerate the
discovery of advanced medicines.
Press releases.
Featured
May 21, 2024
LabGenius raises £35 million led by M Ventures to further develop its ML-driven antibody discovery platform and progress a pipeline of assets towards the clinic
May 21, 2024
May 21, 2024
Sep 18, 2023
LabGenius’ Research Collaboration with Sanofi Yields Positive Results
Sep 18, 2023
Sep 18, 2023
May 15, 2023
LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark
May 15, 2023
May 15, 2023
Apr 4, 2023
LabGenius Appoints Prof Hendrik-Tobias Arkenau and Prof Victor Greiff as Scientific Advisors.
Apr 4, 2023
Apr 4, 2023
Nov 30, 2022
LabGenius Wins Government Innovation Grant To Support The Development Of ML-driven Cancer Therapies
Nov 30, 2022
Nov 30, 2022
Nov 16, 2022
LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer
Nov 16, 2022
Nov 16, 2022
Oct 7, 2022
LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA™
Oct 7, 2022
Oct 7, 2022
Nov 30, 2021
LabGenius appoints Dr. Gino Van Heeke as Chief Scientific Officer
Nov 30, 2021
Nov 30, 2021
Jul 15, 2021
LabGenius announces research collaboration with Ablynx, a Sanofi Company
Jul 15, 2021
Jul 15, 2021
Oct 29, 2020
LabGenius closes series A extension, led by Atomico, bringing total round to $25M
Oct 29, 2020
Oct 29, 2020
Apr 20, 2020
LabGenius appoints Dr. Edwin Moses as Chairman of its Board of Directors
Apr 20, 2020
Apr 20, 2020
In the news.
Featured
Jan 17, 2024
LabGenius' CTO, Leonard Wossnig, discusses the intersection of synthetic biology, high-throughput assays, and machine learning in the quest for cancer drugs with Harry Glorikian
Jan 17, 2024
Jan 17, 2024
Nov 15, 2023
BBC News covers LabGenius and how it harnesses AI in the search for new medicines
Nov 15, 2023
Nov 15, 2023
Nov 9, 2023
LabGenius' CEO, James Field, discusses ML-enabled drug discovery with Patrick Short on the Genetics Podcast
Nov 9, 2023
Nov 9, 2023
Oct 19, 2023
PwC | The Life Sciences Future50
Oct 19, 2023
Oct 19, 2023
Sep 28, 2023
The Bio Report | Leveraging Generative AI to Design Therapeutic Antibodies
Sep 28, 2023
Sep 28, 2023
Sep 18, 2023
SynBioBeta | Machine Learning Enhances Antibody Discovery: A Glimpse into LabGenius and Sanofi's Collaborative Endeavour
Sep 18, 2023
Sep 18, 2023
Sep 18, 2023
TechCrunch | Questions Every VC Needs to Ask About Every AI Startup’s Tech Stack
Sep 18, 2023
Sep 18, 2023
Aug 9, 2023
WIRED Feature | AI is Building Highly Effective Antibodies That Humans Can’t Even Imagine
Aug 9, 2023
Aug 9, 2023
Jul 7, 2023
LabGenius' CEO, James Field, discusses ML-enabled drug discovery as a recent guest on the Business of Biotech podcast
Jul 7, 2023
Jul 7, 2023
Jul 5, 2023
LabGenius featured in the inaugural edition of the Decoding Bio Snapshot
Jul 5, 2023
Jul 5, 2023
Blog posts.
Featured
Jul 28, 2023
Blog post | LabGenius' CTO, Leonard Wossnig, introduces the 5 'V's of drug discovery data in a recent blog post
Jul 28, 2023
Jul 28, 2023
Mar 10, 2023
Get to know LabGenius' CTO, Ex-Rahko co-founder & CEO and former VP of AI Odyssey Therapeutics, Dr Leonard Wossnig.
Mar 10, 2023
Mar 10, 2023
Sep 27, 2022
Q&A with Justin Grace, Senior Data Scientist @ LabGenius
Sep 27, 2022
Sep 27, 2022
Jun 15, 2022
Ex-Google CFO and LabGenius Investor, Patrick Pichette, shares his advice for scaling with efficiency
Jun 15, 2022
Jun 15, 2022
Apr 4, 2022
Q&A with Dr. Dan Foxler, Principal Scientist @ LabGenius
Apr 4, 2022
Apr 4, 2022
Oct 29, 2020
LabGenius tops up Series A to $25M
Oct 29, 2020
Oct 29, 2020
Jun 12, 2020
How to build a platform to design new protein therapeutics
Jun 12, 2020
Jun 12, 2020
Apr 29, 2020
How LabGenius is revolutionising drug discovery with machine learning
Apr 29, 2020
Apr 29, 2020
Mar 6, 2020
Data, drugs, and deep learning
Mar 6, 2020
Mar 6, 2020
Mar 27, 2018
AI-driven protein engineering, Silicon Scientists and startup investment
Mar 27, 2018
Mar 27, 2018
News Header
News Content